University of Texas at Austin Dell Medical School Clinical Neurophysiology

Topics

• Epilepsy research and treatment 5
• Inflammatory Myopathies and Dermatomyositis 4
• Cleft Lip and Palate Research 3
• Acute Ischemic Stroke Management 2
• Amyloidosis: Diagnosis, Treatment, Outcomes 2
• Head and Neck Anomalies 2
• Intensive Care Unit Cognitive Disorders 2
• Intraoperative Neuromonitoring and Anesthetic Effects 2
• Myasthenia Gravis and Thymoma 2
• Amyotrophic Lateral Sclerosis Research 1
• Autoimmune Neurological Disorders and Treatments 1
• Botulinum Toxin and Related Neurological Disorders 1

Most cited

1. Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.

   The Lancet. Neurology · 2023 · 218 citations · Yessar Hussain

2. Safety, tolerability, and efficacy of subcutaneous efgartigimod in patients with chronic inflammatory demyelinating polyradiculoneuropathy (ADHERE): a multicentre, randomised-withdrawal, double-blind, placebo-controlled, phase 2 trial.

   The Lancet. Neurology · 2024 · 95 citations · Yessar Hussain

3. Trial of Intravenous Immune Globulin in Dermatomyositis.

   The New England journal of medicine · 2022 · 163 citations · Yessar Hussain

4. Long-term safety and efficacy of zilucoplan in patients with generalized myasthenia gravis: interim analysis of the RAISE-XT open-label extension study.

   Therapeutic advances in neurological disorders · 2024 · 35 citations · Yessar Hussain

5. Zilucoplan in immune-mediated necrotising myopathy: a phase 2, randomised, double-blind, placebo-controlled, multicentre trial.

   The Lancet. Rheumatology · 2023 · 43 citations · Yessar Hussain

6. Prospective Observational Cohort Study of Tenecteplase Versus Alteplase in Routine Clinical Practice.

   Stroke · 2022 · 57 citations ·